AbbVie (ABBV) Short Interest Ratio & Short Volume → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free ABBV Stock Alerts $166.42 +2.07 (+1.26%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability AbbVie Short Interest DataCurrent Short Volume14,480,000 sharesPrevious Short Volume13,540,000 sharesChange Vs. Previous Month+6.94%Dollar Volume Sold Short$2.36 billionShort Interest Ratio / Days to Cover2.6Last Record DateApril 30, 2024Outstanding Shares1,765,870,000 sharesFloat Size1,760,000,000 sharesShort Percent of Float0.82%Today's Trading Volume5,152,176 sharesAverage Trading Volume5,284,928 sharesToday's Volume Vs. Average97% Short Selling AbbVie ? Sign up to receive the latest short interest report for AbbVie and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatABBV Short Interest Over TimeABBV Days to Cover Over TimeABBV Percentage of Float Shorted Over Time Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. AbbVie Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202414,480,000 shares $2.36 billion +6.9%0.8%2.6 $162.69 4/15/202413,540,000 shares $2.19 billion +3.2%N/A2.4 $161.67 3/31/202413,120,000 shares $2.39 billion -10.7%N/A2.3 $182.10 3/15/202414,690,000 shares $2.61 billion +2.9%0.8%2.7 $177.88 2/29/202414,270,000 shares $2.51 billion -3.3%0.8%2.6 $175.61 2/15/202414,750,000 shares $2.60 billion +7.5%0.8%2.8 $176.61 Get the Latest News and Ratings for ABBV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AbbVie and its competitors with MarketBeat's FREE daily newsletter. 1/31/202413,720,000 shares $2.26 billion +1.2%0.8%2.5 $164.36 1/15/202413,560,000 shares $2.20 billion +12.3%0.8%2.4 $162.40 12/31/202312,080,000 shares $1.87 billion -11.8%0.7%2.2 $154.97 12/15/202313,690,000 shares $2.11 billion +23.0%0.8%2.6 $154.07 11/30/202311,130,000 shares $1.58 billion -0.2%0.6%2.2 $142.35 11/15/202311,150,000 shares $1.53 billion -15.7%0.6%2.4 $137.61 10/31/202313,230,000 shares $1.87 billion +15.3%0.8%3 $141.18 10/15/202311,470,000 shares $1.70 billion -6.8%0.7%2.6 $147.96 9/30/202312,310,000 shares $1.83 billion +3.2%0.7%2.7 $149.06 9/15/202311,930,000 shares $1.81 billion -4.2%0.7%2.4 $152.09 8/31/202312,450,000 shares $1.83 billion -6.1%0.7%2.4 $146.96 8/15/202313,260,000 shares $2.02 billion +15.9%0.8%2.3 $152.12 7/31/202311,440,000 shares $1.71 billion +20.3%0.7%2 $149.58 7/15/20239,510,000 shares $1.29 billion -8.2%0.5%1.6 $136.01 6/30/202310,360,000 shares $1.40 billion -8.4%0.6%1.8 $134.72 6/15/202311,310,000 shares $1.54 billion -0.6%0.6%2 $135.89 5/31/202311,380,000 shares $1.57 billion -4.9%0.7%1.9 $137.96 5/15/202311,970,000 shares $1.75 billion -23.5%0.7%2.1 $146.59 4/30/202315,650,000 shares $2.37 billion +3.4%0.9%2.6 $151.12 4/15/202315,140,000 shares $2.45 billion -7.0%N/A2.6 $161.59 3/31/202316,280,000 shares $2.59 billion +16.0%N/A2.6 $159.37 3/15/202314,040,000 shares $2.16 billion +10.6%N/A2.3 $154.06 2/28/202312,700,000 shares $1.95 billion +8.5%N/A2.3 $153.90 2/15/202311,710,000 shares $1.77 billion +13.7%N/A2.1 $151.06 1/31/202310,300,000 shares $1.52 billion -13.9%N/A1.8 $147.75 1/15/202311,960,000 shares $1.84 billion -7.5%N/A2.2 $153.60 12/30/202212,930,000 shares $2.09 billion -4.8%N/A2.5 $161.61 12/15/202213,580,000 shares $2.21 billion -0.6%N/A2.4 $163.10 11/30/202213,660,000 shares $2.20 billion +5.8%N/A2.4 $161.18 11/15/202212,910,000 shares $1.98 billion -6.5%N/A2.3 $153.04 10/31/202213,800,000 shares $2.02 billion -1.4%N/A2.6 $146.40 10/15/202214,000,000 shares $2.00 billion +5.3%N/A2.6 $142.94 9/30/202213,290,000 shares $1.78 billion +2.6%N/A2.4 $134.21 9/15/202212,950,000 shares $1.85 billion +13.8%N/A2.4 $142.51[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. ABBV Short Interest - Frequently Asked Questions What is AbbVie's current short interest? Short interest is the volume of AbbVie shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 14,480,000 shares of ABBV short. 0.82% of AbbVie's shares are currently sold short. Learn More on AbbVie's current short interest. What is a good short interest ratio for AbbVie? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABBV shares currently have a short interest ratio of 3.0. Learn More on AbbVie's short interest ratio. Which institutional investors are shorting AbbVie? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AbbVie: Walleye Trading LLC, Jane Street Group LLC, BlueCrest Capital Management Ltd, PEAK6 Investments LLC, JPMorgan Chase & Co., Twin Tree Management LP, SG Americas Securities LLC, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., SpiderRock Advisors LLC, Oak Hill Wealth Advisors LLC, Simplex Trading LLC, Wealth Enhancement Advisory Services LLC, Clarity Financial LLC, Portman Square Capital LLP, Curated Wealth Partners LLC, Nomura Holdings Inc., and Readystate Asset Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for AbbVie? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.82% of AbbVie's floating shares are currently sold short. Is AbbVie's short interest increasing or decreasing? AbbVie saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 14,480,000 shares, an increase of 6.9% from the previous total of 13,540,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is AbbVie's float size? AbbVie currently has issued a total of 1,765,870,000 shares. Some of AbbVie's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AbbVie currently has a public float of 1,760,000,000 shares. How does AbbVie's short interest compare to its competitors? 0.82% of AbbVie's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to AbbVie: Merck & Co., Inc. (0.74%), Johnson & Johnson (0.74%), Pfizer Inc. (1.10%), Bristol-Myers Squibb (1.38%), Zoetis Inc. (1.13%), Moderna, Inc. (6.26%), IDEXX Laboratories, Inc. (2.07%), Seagen Inc. (5.10%), IQVIA Holdings Inc. (1.62%), BioNTech SE (1.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short AbbVie stock? Short selling ABBV is an investing strategy that aims to generate trading profit from AbbVie as its price is falling. ABBV shares are trading up $2.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against AbbVie? A short squeeze for AbbVie occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABBV, which in turn drives the price of the stock up even further. How often is AbbVie's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABBV, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Merck & Co., Inc. Short Squeeze Johnson & Johnson Short Squeeze Pfizer Short Squeeze Bristol-Myers Squibb Short Squeeze Zoetis Short Squeeze Moderna Short Squeeze IDEXX Laboratories Short Squeeze Seagen Short Squeeze IQVIA Short Squeeze BioNTech Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:ABBV) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward Press